United States · FDA National Drug Code directory
PROXEN NP 660
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69729-123_0d811063-82c1-bf9f-e063-6294a90aa371
- Product NDC
- 69729-123
- Form
- TABLET
- Composition / generic term
- Naproxen Sodium
- Labeler
- OPMX LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20231107
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN SODIUM — 220 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (69729-123-12) / 12 TABLET in 1 BLISTER PACK · 69729-123-12
- 2 BLISTER PACK in 1 CARTON (69729-123-24) / 12 TABLET in 1 BLISTER PACK · 69729-123-24
- 50 POUCH in 1 CARTON (69729-123-50) / 2 TABLET in 1 POUCH · 69729-123-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →